An open-label, randomized, phase 3 study of the efficacy and safety of antithrombin gamma in patients with sepsis-induced disseminated intravascular coagulation syndrome

  • Shigeatsu Endo
  • , Ryutaro Shimazaki
  • , Satoshi Gando
  • , Shigeto Oda
  • , Yasuhiro Ootomo
  • , Masanao Miura
  • , Shinji Ogura
  • , Yutaka Eguchi
  • , Joji Kotani
  • , Norio Yamashita
  • , Hiroyasu Ishikura
  • , Yuichiro Sakamoto
  • , Takeshi Takahashi
  • , Yasushi Suzuki
  • , Shigeki Kushimoto
  • , Nobuya Kitamura
  • , Naoyuki Matsuda
  • , Takahiro Fujita
  • , Mitsuhide Kitano
  • , Junko Yamaguchi
    • Yoshikazu Yasuda, Hayato Takayama, Toshiharu Tanaka, Tetsuya Matsuoka, Tetsuhiro Takei, Tsuyoshi Hatada, Masahiro Tamashiro, Satoshi Fujimi, Osamu Nishida, Kazuhito Tamehiro, Junichi Maehara, Shinsuke Fujiwara, Hideo Wada

Research output: Contribution to journal › Article › peer-review

27   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'An open-label, randomized, phase 3 study of the efficacy and safety of antithrombin gamma in patients with sepsis-induced disseminated intravascular coagulation syndrome'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology